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Palindromic AT-rich repeats (PATRRs) on chromosomes 11q23 and 22q11 at the constitutional t(11;22) breakpoint
are predicted to induce genomic instability, which mediates the translocation. A PCR-based translocation-detection
system for the t(11;22) has been developed with PCR primers flanking the PATRRs of both chromosomes, to
examine the involvement of the PATRRs in the recurrent rearrangement. Forty unrelated carriers of the t(11;22)
balanced translocation, plus two additional, independent cases with the supernumerary-der(22) syndrome, were
analyzed to compare their translocation breakpoints. Similar translocation-specific junction fragmentswere obtained
from both derivative chromosomes in all 40 carriers of the t(11;22) balanced translocation and from the der(22)
in both of the offspring with unbalanced supernumerary-der(22) syndrome, suggesting that the breakpoints in all
cases localize within these PATRRs and that the translocation is generated by a similar mechanism. This PCR
strategy provides a convenient technique for rapid diagnosis of the translocation, indicating its utility for prenatal
and preimplantation diagnosis in families including carriers of the balanced translocation.
The t(11;22)(q23;q11) is the only known recurrent, non-
Robertsonian constitutional translocation in humans.
Carriers of this balanced translocation usually have no
clinical symptoms and are often identified after the birth
of offspring with an unbalanced form of the translo-
cation, the supernumerary-der(22)t(11;22) syndrome.
Patients with the supernumerary-der(22) syndrome have
a distinctive phenotype, which consists of severe mental
retardation, preauricular tag or sinus, ear anomaly, cleft
or high-arched palate, micrognathia, heart defects, and
genital abnormalities in the male (Fraccaro et al. 1980;
Zackai and Emanuel 1980). This syndrome most often
arises through 3:1 meiotic malsegregation of the bal-
anced translocation in meiosis (Shaikh et al. 1999), and
clustered breakpoints have been reported in numerous
unrelated families (Edelmann et al. 1999; Shaikh et al.
1999).
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In our previous study, the der(11) and der(22) junction
fragments of one carrier of the t(11;22) balanced trans-
location were cloned, which demonstrated that the
breakpoints localize within palindromic AT-rich repeats
(PATRRs) on both chromosome 11 and chromosome 22
(Kurahashi et al. 2000). Identification of the sequence
of both junction fragments permitted the generation of
translocation-specific PCR products from both the
der(11) and the der(22) in this individual. Analysis of
the junction fragments of two additional, unrelated car-
riers suggested similar breakpoints. These findings pro-
vided the impetus to develop a PCR approach for di-
agnostic and analytic purposes. Initially, we designed
primer pairs flanking the PATRRs both on chromosome
11 and on chromosome 22, to amplify the junction frag-
ments of the der(11) and the der(22). However, because
the breakpoint regions are extremely AT rich, they were
difficult to amplify without generation of nonspecific
products from other chromosomal regions. Thus, inter-
nal PCR primers were designed, and a nested-PCR
method was applied to produce t(11;22) transloca-
tion–specific products (fig. 1). With the primers and con-
ditions shown in table 1, junction fragments from the
der(11) and from the der(22) could be amplified from a
carrier of the t(11;22) (fig. 2, sample 4 [case 16 in table
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Figure 1 PCR primers used in analysis of the t(11;22) breakpoint. The white portion of the sequences denotes the PATRR, which includes
the breakpoint region; gray portions denote chromosome 11; and hatched portions denote chromosome 22. PCR primers are indicated, with
their orientation shown by arrows.
2]). Family members with the same translocation pro-
duce the same PCR products (data not shown), whereas
family members with a normal karyotype do not yield
PCR products (fig. 2, samples 1–3 and 5). The proband
who carries the supernumerary der(22) in addition to
normal chromosomes 11 and 22 yields only the der(22)
junction fragment (fig. 2, sample 6). These results sug-
gested that this nested-PCR approach was t(11;22)-
breakpoint specific.
With this PCR approach, analysis of the breakpoints
of 40 unrelated carriers of the t(11;22) balanced trans-
location, as well as of 2 additional cases, who had the
supernumerary-der(22) syndrome, was performed. Some
characteristics associated with these cases are summa-
rized in table 2. All carriers had been previously diag-
nosed, by conventional cytogenetic studies, as having the
t(11;22)(q23;q11). All 40 carriers of the balanced trans-
location yielded translocation-specific PCR products
from both the der(11) and the der(22), whereas the 2
cases with supernumerary-der(22) syndrome produced
PCR products derived from the der(22) only. The gen-
eration of PCR products from all individuals suggested
that all of the t(11;22) breakpoints are located within
the same PATRRs on both chromosome 11 and chro-
mosome 22. In addition, all cases resulted in amplifi-
cation of PCR products of similar size, with one excep-
tion. Case 23 yielded different-sized PCR products such
that the product from the der(11) was larger whereas
that from the der(22) was smaller. Sequence analysis of
this individual’s PCR products demonstrated a break-
point within the same PATRRs but at a location different
from that of the others. For the remaining 41 cases, the
sequences of the PCR products were almost identical
with regard to the breakpoint regions of the derivative
chromosomes, suggesting that the breakpoints on both
11q23 and 22q11 are quite similar in their location.
However, it should be noted that only the der(22) junc-
tion fragment was analyzed in the two cases of super-
numerary-der(22) syndrome.
The similarity between the breakpoints of multiple
independent families of varied ethnic and racial back-
grounds is striking. The majority of the families are
white, whereas two are Hispanic (cases 14 and 31),
one is Lebanese (case 17), one is African-American
(case 32), and another is Palestinian (case 41). Fur-
thermore, our samples included four de novo carriers
(cases 8, 16, 39, and 40) and two families (cases 1 and
23) in which there is no der(22) proband whose
breakpoints are all alike. We also utilized this PCR
approach to confirm a diagnosis of supernumerary-
der(22) syndrome in an individual with 47,XY,mar
(case 42) whose condition had been suspected on the
basis of clinical features. In this case, both parents were
karyotypically normal, with confirmed paternity, sug-
gesting the occurrence of both the de novo transloca-
tion and 3:1 malsegregation events in the same meiosis.
Taken together, the similarity of breakpoints in cases
of varied ethnicity and de novo rearrangement imply
that breakpoint clustering is the result of a common
chromosomal breakage mechanism, rather than being
due to either founder effect or identity by descent. In
our previous work, both the der(11) and the der(22)
junction fragments of a t(11;22) have been analyzed
(Kurahashi et al. 2000). We identified PATRRs located
at the breakpoint regions on 11q23 and 22q11. The
data presented here, which demonstrate that all of the
translocation breakpoints are within these PATRRs,
support the hypothesis that numerous t(11;22) consti-
tutional translocations arise by the same mechanism.
We have previously suggested that the palindromic se-
quences flanking the breakpoint on both 11q23 and
22q11 might facilitate the formation of hairpin or cru-
ciform structures. Furthermore, AT-rich sequences have
a lower melting temperature, which permits hairpin
structures to form at physiological temperatures. In the
presence of these structures, hairpin-nicking activity is
likely to create double-stranded breaks on both chro-
mosomes (Akgun et al. 1997). Illegitimate reciprocal
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Table 1
Primers Used for PCR Amplification of Junction Fragments
der(11) PRIMERS der(22) PRIMERS
PCR Name Sequence Name Sequence
Firsta c14irev 5′-GGAAGTTAGAGAAAACTGAGAA-3′ c14hfor 5′-AACACTCCCACTGACAGCTA-3′
JF22.2 5′-CCTCCAACGGATCCATACT-3′b JF22.2 5′-CCTCCAACGGATCCATACT-3′b
Secondc JFN11 5′-CAGAAAGGGAGAGCATGTAG-3′ JFN11.2 5′-GGTTGAAGAATCTTGGCTGG-3′
JFN22 5′-CGTTGAAGGATGCAGGATGT-3′ JFN22 5′-CGTTGAAGGATGCAGGATGT-3′
a Conditions are as follows: 5 cycles of 94C for 30 s, 58C for 30 s, and 72C for 1 min, followed by 35 cycles
of 94C for 30 s, 56C for 30 s, and 72C for 1 min.
b Corresponds to primer “c” in the study by Kehrer-Sawatzki et al. (1997).
c Conditions are as follows: 35 cycles of 94C for 15 s, 58C for 15 s, and 72C for 30 s.
exchange between such disrupted chromosomes 11 and
22 would lead to the formation of a translocation be-
tween them.
Despite the striking similarity of these 42 cases, com-
parisons of the sequence of their junction fragments re-
vealed some slight differences between them. It is not
yet clear whether this reflects a subtle difference in the
individual breakpoints or some level of polymorphism
within the AT-rich repeats. As has been reported else-
where (Kurahashi et al. 2000), the exact location of the
breakpoints at the nucleotide level cannot, as yet, be
determined. One reason is that, on both chromosome
11 and chromosome 22, there are numerous ATs within
the PATRRs, which makes them resemble one another.
Furthermore, despite numerous attempts, there is still a
gap in the sequence of this region from the normal chro-
mosome 22 (Dunham et al. 1999; Kurahashi et al. 2000;
Shaikh et al. 2000).
Five carriers of the balanced t(11;22) who had an
abnormal phenotype (cases 36–40) were identified
among the study subjects. One of them (case 38) has
mental retardation, lactic acidosis, and autism; another
has holoprosencephaly (case 36). The remaining three
cases presented with multiple congenital anomalies, of
which two are carriers of a de novo balanced translo-
cation (cases 39 and 40). PCR analysis showed that the
breakpoints for all five cases localize within the same
PATRR, on chromosomes 11 and 22. The breakpoints
on chromosome 22q11 are located within LCR-B (low
copy repeat B) (Shaikh et al. 2000), one of sever-
al large duplications or chromosome 22–specific LCRs
(Edelmann et al. 1999; Shaikh et al. 2000). Although
the NF1L components of LCR-A, LCR-B, and LCR-D
are very AT rich, only LCR-B contains a PATRR. Fur-
thermore, the chromosome 22–specific LCRs are com-
posed primarily of pseudogenes and interspersed re-
peat components and appear to contain few, if any,
functional genes (Shaikh et al. 2000). Analysis of the
sequence of the breakpoint-spanning bacterial artificial
chromosome on 11q23 (i.e., b442e11) identified no
genes disrupted by the translocation (Kurahashi et al.
2000), lending further support to the hypothesis that the
abnormal phenotype in these five carriers of the trans-
location is not directly attributable to a variant location
of the translocation. In these five individuals, an uni-
dentified gene defect may coexist with the translocation,
or some epigenetic factor may be responsible for the
abnormal phenotype. Alternatively, low-level somatic
mosaicism for der(22) or der(22) might be possible
in these cases.
In a previous study of families with the t(11;22), the
incidence of breast cancer was noted to be significantly
higher among carriers of the balanced translocation, sug-
gesting a predisposition to breast cancer (Lindblom et
al. 1994). Furthermore, a putative breast cancer gene
has been mapped to 11q23, by loss-of-heterozygosity
analysis (Carter et al. 1994; Hampton et al. 1994). These
findings have led to the suggestion that a putative breast
cancer gene could be disrupted by or located in the vi-
cinity of the t(11;22) breakpoint on 11q23. In the pre-
sent study, one of the carriers of the t(11;22) (case 2)
had bilateral breast cancer, diagnosed at 39 and 59 years
of age. PCR analysis demonstrated that her translocation
breakpoint is located within the same PATRRs, sug-
gesting that a gene at the t(11;22) breakpoint is not
responsible for the breast cancer in this individual. This
does not eliminate the possibility of either a “position
effect” generated by the translocation or linkage to a
gene in the vicinity of the translocation, but it should
be noted that numerous carriers of the same translo-
cation, in the families that we have previously studied
(Zackai and Emanuel 1980; E.H.Z. and B.S.E., unpub-
lished results), are not similarly affected. An alternative
explanation for the breast cancer association noted in
some carriers of the t(11;22) might be related to the
potential for the small der(22) chromosome to be lost
by nondisjunction during mitosis. A breast cancer–
susceptibility gene (tumor-suppressor locus) either on
proximal 22q or on distal 11q could be functionally
inactivated by somatic loss of the der(22) in breast tissue,
accompanied by a mutation of the gene on the normal
homologue. Thus, loss of function of the gene product
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Figure 2 PCR results from one t(11;22) family. a, Pedigree of t(11;22) family. The blackened circle denotes the proband, who has the
supernumerary-der(22) syndrome, and the circle with a black dot denotes the mother who is a carrier of the balanced translocation. b, PCR
analysis for der(11). c, PCR analysis for der(22). Lanes M show 1-kb plus DNA ladder (GIBCO BRL); lanes P show results for the carrier of
the t(11;22) balanced translocation (case 1), who serves as a positive control; the numbered lanes show results for DNA from individuals with
the corresponding ID number in the pedigree Size markers (in bp) are indicated. The largest band is the authentic PCR product (arrows). The
ladder is an artifact that originates from “stutter bands,” on amplification of the AT-rich repeat.
could lead to tumor formation. Additional studies of
breast cancer specimens from carriers of the t(11;22) that
utilize either this PCR assay or a FISH approach to detect
loss of the der(22) chromosome in tumor cells might be
warranted.
These data highlight the utility of PCR for detection
of the 11;22 translocation. The advantages of this PCR
assay are that (a) it is rapid, (b) only a small quantity
of DNA is required for screening, and (c) the DNA can
be acquired by minimally invasive methods. Thus, DNA
isolated from buccal swabs can be used to assess carrier
or proband status. Since all of the t(11;22) cases studied
yielded translocation-specific PCR products that were
absent from normal individuals, the specificity of this
assay is high. For example, despite the fact that his par-
ents were cytogenetically normal, case 42 was con-
firmed, by the PCR assay, as being a case of de novo
supernumerary der(22). Furthermore, the sensitivity for
breakpoint detection should also be quite high, allowing
for detection of mosaicism. In this study, one individual
is a mosaic for the t(11;22) (case 7). Although the per-
centage of t(11;22) cells in peripheral blood lymphocytes
in this case is 80%, which should be easily detected by
standard cytogenetic evaluation, very-low-level mosai-
cism in other instances might be missed by routine cy-
togenetic diagnosis. Thus, it is possible that either parent
of case 42 might be a low-level t(11;22) mosaic that
routine cytogenetic analysis failed to detect. The method
that this study provides for detection of low-level mo-
saicism will allow more-accurate assignment of recur-
rence risk in such cases.
In families segregating the translocation, pregnancies
can now be monitored earlier and more expeditiously,
to detect the supernumerary der(22) or the t(11;22) by
PCR analysis of uncultured amniotic fluid or villi. How-
ever, since most families are ascertained after 3:1 meiotic
segregation of the der(22) from female carriers of the
t(11;22) (table 2), caution must be exercised, to avoid
maternal-cell contamination in such cases. Furthermore,
we recommend confirmation on cultured amniocytes or
villi. This PCR approach could also be applied as a more
sensitive method for preimplantation genetic diagnosis
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Table 2
Summary of 42 Cases of t(11;22)
Case Patient ID Race Associated Finding(s)
Carriers of balanced translocation:
Unaffected:
1a CH99-200 White No der(22) in pedigree
2 CH97-82 White der(22) in twins; bilateral breast cancer
3a CH97-62 White
4 CH92-224L White
5 CH95-257 White
6 CH94-188L White
7 P91-007F White Mosaic for t(11;22), 46,XX(20%)/46,XX,t(11;22)(80%)
8b CH97-78 White Carrier of de novo t(11;22)
9a CH97-120 White
10 CH96-180 White
11 CH97-03 White
12c CH97-181 White
13d CH98-40 White
14 CH98-120 Hispanic
15 CH98-169 White
16 CH97-48 White Carrier of de novo t(11;22)
17 CH91-221L Lebanese
18 P89-43 White Aunt of der(22) meiosis II nondisjunction
19 CH96-123 White
20 CH00-09 White
21d CH00-32 White
22 CH91-258L White
23 CH93-075L White No der(22) in pedigree
24 P90-34L White
25 CH2227 White
26 D00-28 White
27 CH98-229 White
28 CH94-037L White
29 CH2217 White
30 CH91-182L White
31 CH92-360L Hispanic
32e GM03372 African American
33e GM04403 White
34e GM06229 White
35 IARC322 White
Abnormal phenotype:
36 CH91-150F White Carrier of balanced translocation who had holoprosencephaly
37 CH97-33 White Carrier of balanced translocation who had an abnormal phenotype
38 P91-015L White Carrier of balanced translocation who had mental retardation, lactic acidosis, and autism
39 D97-309 White Carrier of de novo translocation who had an abnormal phenotype
40 D98-78 White Carrier of de novo translocation who had an abnormal phenotype
Supernumerary-der(22) syndrome:
41d CH93-166L Palestinian
42 D9-61 White De novo der(22)
a Reported in our previous work (Kurahashi et al. 2000).
b Previously reported by Zackai and Emanuel (1980), as “family C.”
c Previously reported by Zackai and Emanuel (1980), as “family B.”
d der(22) transmitted by a father who was a carrier.
e Obtained from Coriell Cell Repositories (Camden, NJ).
(PGD) during in vitro fertilization (Fung et al. 1999).
We recommend blastomere biopsy on an eight-cell em-
bryo derived from a parent who is a carrier of the
t(11;22). Since we have identified one individual with
supernumerary-der(22) syndrome who had a karyo-
type of 47,XY,t(11;22)(q23;q11),der(22)mat (the in-
dex case for the unbalanced translocation in family 18)
caused by nondisjunction during meiosis II, we recom-
mend that biopsy of the first polar body be avoided for
PGD in t(11;22) diagnosis. Furthermore, it is important
that FISH or quantitative PCR be undertaken, to confirm
the presence of only a single der(22) when both deriv-
ative chromosomes are detected prenatally by PCR. In
conclusion, this PCR assay provides a cost-effective
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method to rapidly detect translocation-specific junction
fragments derived from either the der(11) or the der(22).
PCR analysis can provide an alternative to conventional
cytogenetics, as a rapid diagnostic procedure to detect
carriers of the t(11;22) as well as to diagnose the su-
pernumerary-der(22) syndrome in affected individuals.
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